CoTZ Face Prime and Protect SPF 40 (Tinted)
- Product NDC
- 58892-354
- 11-digit product format
- 588920354
- Labeler code
- 58892
- Product ID
- 58892-354_87f5edec-e860-418b-99d8-317d57624d1b
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Titanium Dioxide, Zinc Oxide
- Dosage form
- CREAM
- Route
- TOPICAL
- Labeler
- Fallien Cosmeceuticals, LTD
- Application
- M020
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2012-06-26
- Substance
- TITANIUM DIOXIDE; ZINC OXIDE
- Active strength
- 80; 38 mg/g; mg/g
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- CoTZ Face Prime and Protect SPF 40 (Tinted)
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| TITANIUM DIOXIDE | 80 mg/g |
| ZINC OXIDE | 38 mg/g |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 15FIX9V2JP, SOI2LOH54Z |
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 58892-354-45 | CoTZ Face Prime and Protect SPF 40 (Tinted) | 1 in 1 CARTON | CREAM | 1 | | 2 |
| 58892-354-45 | CoTZ Face Prime and Protect SPF 40 (Tinted) | 42.5 g in 1 TUBE | CREAM | 42.5 | | 2 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 58892-354 | COTZ FACE PRIME AND PROTECT SPF 40 (TINTED) (TITANIUM DIOXIDE, ZINC OXIDE) CREAM [FALLIEN COSMECEUTICALS, LTD] | 2 | Current NDC, Legacy NDC, 2 package rows | 20250124_1088fbf6-5790-490d-b272-ec281b4b76fa.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 58892-354-45 | 58892035445 | 1 TUBE in 1 CARTON (58892-354-45) / 42.5 g in 1 TUBE | 1 tube | 2021-05-01 | 0000-00-00 | No | No | Current |